Clinical Trial Update: Algeron (Cepeginterferon Alfa-2b) Compared With PegIntron (Peginterferon Alfa-2b) for Treatment of Chronic Hepatitis C [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 trial comparing Algeron (cepeginterferon alfa-2b) with PegIntron (peginterferon alfa-2b) for chronic hepatitis C, with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Algeron (cepeginterferon alfa-2b)
• PegIntron (pegylated interferon alfa-2b)

Snippet

Sponsor: Biocad | Conditions: Hepatitis, Hepatitis C | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2015-08-18